Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $107.12 and traded as low as $103.35. bioMérieux shares last traded at $103.35, with a volume of 8 shares.
bioMérieux Price Performance
The firm has a 50-day moving average of $107.12 and a 200 day moving average of $107.84.
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Articles
- Five stocks we like better than bioMérieux
- What is a Bond Market Holiday? How to Invest and Trade
- Top 3 Investment Themes to Watch for in 2025
- What is the Euro STOXX 50 Index?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
